

Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Pulmonary tuberculosis | D014397 | EFO_1000049 | A15 | — | 1 | — | — | — | 1 |
| Multidrug-resistant tuberculosis | D018088 | EFO_0007381 | — | — | 1 | — | — | — | 1 |
| Drug common name | Sutezolid |
| INN | sutezolid |
| Description | Sutezolid (PNU-100480, PF-02341272) is an oxazolidinone antibiotic currently in development as a treatment for extensively drug-resistant tuberculosis.
It differs from linezolid by replacement of the morpholine oxygen with a sulfur atom.
|
| Classification | Small molecule |
| Drug class | oxazolidinone antibacterials |
| Image (chem structure or protein) | ![]() |
| Structure (InChI/SMILES or Protein Sequence) | CC(=O)NC[C@H]1CN(c2ccc(N3CCSCC3)c(F)c2)C(=O)O1 |
| PDB | — |
| CAS-ID | 165800-04-4 |
| RxCUI | — |
| ChEMBL ID | CHEMBL288149 |
| ChEBI ID | — |
| PubChem CID | 465951 |
| DrugBank | DB11905 |
| UNII ID | 3A71182L8P (ChemIDplus, GSRS) |
